Literature DB >> 33530911

Atrial Natriuretic Peptide: Structure, Function, and Physiological Effects: A Narrative Review.

Sanjana Rao1, Camilo Pena1, Scott Shurmur1, Kenneth Nugent1.   

Abstract

Atrial natriuretic peptide (ANP) is a cardiac peptide with multiple physiological effects, including natriuresis, blood pressure regulation, and renin-angiotensin-aldosterone system (RAAS) antagonism. Pre-proANP is synthesized in the atria and must be extensively cleaved by the protease corin to produce the mature 28 amino acid ANP. The downstream signaling pathway of ANP acts through the guanylyl cyclase receptor and the second messenger cGMP. Studies on ANP's physiological effects have demonstrated its activity on channels present in the apical membrane in the renal nephron, potentially inhibiting or decreasing sodium reabsorption. Recent research has also identified several clinical conditions, such as dilated cardiomyopathy, renal failure, and aging, associated with increased and decreased ANP levels. ANP levels could serve as a potential biomarker for the diagnosis of acute stages of heart failure, and ANP infusion could have a role in the management of acute or chronic heart failure. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Atrial natriuretic peptide; cGMP; corin; guanylyl cyclase receptor; heart failure.; hypertension; renin

Mesh:

Substances:

Year:  2021        PMID: 33530911      PMCID: PMC8950497          DOI: 10.2174/1573403X17666210202102210

Source DB:  PubMed          Journal:  Curr Cardiol Rev        ISSN: 1573-403X


  93 in total

Review 1.  Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation.

Authors:  L R Potter; T Hunter
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure.

Authors:  K Tsunoda; F A Mendelsohn; P M Sexton; S Y Chai; G P Hodsman; C I Johnston
Journal:  Circ Res       Date:  1988-01       Impact factor: 17.367

Review 3.  Diverse biological actions of atrial natriuretic peptide.

Authors:  B M Brenner; B J Ballermann; M E Gunning; M L Zeidel
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

4.  Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes.

Authors:  Faye Wu; Wei Yan; Junliang Pan; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

5.  Plasma levels of atrial and brain natriuretic peptides in apparently healthy subjects: Effects of sex, age, and hemoglobin concentration.

Authors:  Mareomi Hamada; Yuji Shigematsu; Masayuki Takezaki; Shuntaro Ikeda; Akiyoshi Ogimoto
Journal:  Int J Cardiol       Date:  2016-11-09       Impact factor: 4.164

6.  Heart atria granularity effects of changes in water-electrolyte balance.

Authors:  A J De Bold
Journal:  Proc Soc Exp Biol Med       Date:  1979-09

7.  A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.

Authors:  I Kishimoto; K Rossi; D L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.

Authors:  W Yan; F Wu; J Morser; Q Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 9.  Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones.

Authors:  E G Erdös; R A Skidgel
Journal:  FASEB J       Date:  1989-02       Impact factor: 5.191

Review 10.  Review series: The cell biology of renal filtration.

Authors:  Rizaldy P Scott; Susan E Quaggin
Journal:  J Cell Biol       Date:  2015-04-27       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.